PsychedelicNewsBreaks – Microdose Psychedelic Insights Shares Agenda Information for Psychedelic Capital: July 2021 Conference

Microdose Psychedelic Insights, a cutting-edge media company focused around promoting content, financial analysis and events designed to drive the psychedelics industry into the forefront of modern medicine, has announced information about its Psychedelic Capital: July 2021 conference. The all-virtual event is scheduled for July 29, 2021 and is designed to shine the spotlight on some of the industry’s top companies, latest IPOs and newest opportunities; the conference presentations also provide deep insights into relevant and timely industry topics. Included in the conference is a focus on psychedelic medicine investment, which includes opportunities for investors and attendees to interact with a curated group of CEOs, capital advisors and investment luminaries from around the world. The conference agenda includes an introductory address from Microdose Psychedelic Insights CEO Patrick Moher and the Conscious Fund founding partner Richard Skaife. The conference also features panel discussions and a number of corporate presentations as well as an investor roundtable focused on pressing issues that impact the global psychedelics industry. One of the main objectives of the conference is to encourage and support attendees in building relationships, networking with professionals from across the psychedelics industry, and gaining access to exciting and ground-breaking pre-IPO investment opportunities within the wider sector.

To register for the event, visit https://ibn.fm/0HUFh

To view the full press release, visit https://ibn.fm/kjn2l

About Microdose Psychedelic Insights

Microdose Psychedelic Insights is dedicated to being a guide to the psychedelic medicine industry. With a vision to shift the world’s perception of psychedelic medicine, the organization distributes and creates the most compelling content, financial analysis, engaging events and ground-breaking education to drive the psychedelics industry to the forefront of modern medicine. For more information about the company, visit www.Microdose.buzz.

About PsychedelicNewsWire

PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.

To receive instant SMS alerts, text “Groovy” to 888-902-4192 (U.S. Mobile Phones Only)

For more information please visit https://www.psychedelicnewswire.com

Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.psychedelicnewswire.com/Disclaimer

Do you have questions or are you interested in working with PNW? Ask our Editor

PsychedelicNewsWire (PNW)
San Francisco, California
www.psychedelicnewswire.com
415.949.5050 Office
Editor@PsychedelicWire.com

PsychedelicNewsWire is part of the InvestorBrandNetwork.